|
1
|
Zhang SX, Zhou YM, Xu W, Tian LG, Chen JX,
Chen SH, Dang ZS, Gu WP, Yin JW, Serrano E, et al: Impact of
co-infections with enteric pathogens on children suffering from
acute diarrhea in southwest China. Infect Dis Poverty. 5:642016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Drossman DA: Functional gastrointestinal
disorders: History, Pathophysiology, Clinical Features and Rome IV.
Gastroenterology. Feb 19–2016.(Epub ahead of print). doi:
10.1053/j.gastro.2016.02.032. View Article : Google Scholar
|
|
3
|
Guandalini S: Probiotics for prevention
and treatment of diarrhea. J Clin Gastroenterol. 45
(Suppl):S149–S153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Jia CS, Shi J, Wang JL, Li XF,
Zhang XP, Sun YH and Qin L: Meta analysis of effectiveness of
acupoint application therapy for infantile diarrhea. Zhen Ci Yan
Jiu. 38:319–323. 2013.(In Chinese). PubMed/NCBI
|
|
5
|
Riaz M, Alam S, Malik A and Ali SM:
Efficacy and safety of Saccharomyces boulardii in acute
childhood diarrhea: A double blind randomised controlled trial.
Indian J Pediatr. 79:478–482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Micklefield G: Saccharomyces boulardii in
the treatment and prevention of antibiotic-associated diarrhea. MMW
Fortschr Med. 156 (Suppl 1):18–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Czerucka D and Rampal P: Experimental
effects of Saccharomyces boulardii on diarrheal pathogens.
Microbes Infect. 4:733–739. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szajewska H, Skórka A, Ruszczyński M and
Gieruszczak-Białek D: Meta-analysis: Lactobacillus GG for treating
acute diarrhoea in children. Aliment Pharmacol Ther. 25:871–881.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murzyn A, Krasowska A, Augustyniak D,
Majkowska-Skrobek G, Łukaszewicz M and Dziadkowiec D: The effect of
Saccharomyces boulardii on Candida albicans-infected
human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol
Lett. 310:17–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moré MI and Swidsinski A: Saccharomyces
boulardii CNCM I-745 supports regeneration of the intestinal
microbiota after diarrheic dysbiosis - a review. Clin Exp
Gastroenterol. 8:237–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McFarland LV: Can Saccharomyces
boulardii prevent antibiotic-associated diarrhea in children?
Nat Clin Pract Gastroenterol Hepatol. 2:262–263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qamar A, Aboudola S, Warny M, Michetti P,
Pothoulakis C, LaMont JT and Kelly CP: Saccharomyces
boulardii stimulates intestinal immunoglobulin A immune
response to Clostridium difficile toxin A in mice. Infect
Immun. 69:2762–2765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Mahony L, McCarthy J, Kelly P, Hurley G,
Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, et
al: Lactobacillus and bifidobacterium in irritable
bowel syndrome: Symptom responses and relationship to cytokine
profiles. Gastroenterology. 128:541–551. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang ZH, Gao QY and Fang JY: Meta-analysis
of the efficacy and safety of Lactobacillus-containing and
Bifidobacterium-containing probiotic compound preparation in
Helicobacter pylori eradication therapy. J Clin
Gastroenterol. 47:25–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meile L, Le Blay G and Thierry A: Safety
assessment of dairy microorganisms: Propionibacterium and
Bifidobacterium. Int J Food Microbiol. 126:316–320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Shimizu T, Hosaka A, Kaneko N,
Ohtsuka Y and Yamashiro Y: Effects of bifidobacterium breve
supplementation on intestinal flora of low birth weight infants.
Pediatr Int. 46:509–515. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin HZ, Fan XB, Hang XM, Li KB and Yang H:
Analysis of the probiotic Bifidobacterium and Lactobacillus
community in child intestinal flora. Wei Sheng Wu Xue Bao.
45:567–570. 2005.(In Chinese). PubMed/NCBI
|
|
18
|
Grönlund MM, Gueimonde M, Laitinen K,
Kociubinski G, Grönroos T, Salminen S and Isolauri E: Maternal
breast-milk and intestinal bifidobacteria guide the compositional
development of the Bifidobacterium microbiota in infants at
risk of allergic disease. Clin Exp Allergy. 37:1764–1772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reinherz EL and Schlossman SF: Current
concepts in immunology: Regulation of the immune response - inducer
and suppressor T-lymphocyte subsets in human beings. N Engl J Med.
303:370–373. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fischbach W, Andresen V, Eberlin M, Mueck
T and Layer P: A comprehensive comparison of the efficacy and
tolerability of racecadotril with other treatments of acute
diarrhea in adults. Front Med (Lausanne). 3:442016.PubMed/NCBI
|
|
21
|
Bern C, Martines J, de Zoysa I and Glass
RI: The magnitude of the global problem of diarrhoeal disease: A
ten-year update. Bull World Health Organ. 70:705–714.
1992.PubMed/NCBI
|
|
22
|
Benninga MA, Faure C, Hyman PE, St James
Roberts I, Schechter NL and Nurko S: Childhood functional
gastrointestinal disorders: Neonate/toddler. Gastroenterology.
150:1443–1455. 2016. View Article : Google Scholar
|
|
23
|
Turin CG and Ochoa TJ: The role of
maternal breast milk in preventing infantile diarrhea in the
developing world. Curr Trop Med Rep. 1:97–105. 2014.PubMed/NCBI
|
|
24
|
Shane AL, Mody RK, Crump JA, Tarr PI,
Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, et
al: Infectious Diseases Society of America Clinical Practice
Guidelines for the diagnosis and management of infectious diarrhea.
Clin Infect Dis. 65:e45–e80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maeda I, Siddiki MS, Nozawa-Takeda T,
Tsukahara N, Tani Y, Naito T and Sugita S: Population abundance of
potentially pathogenic organisms in intestinal microbiome of jungle
crow (Corvus macrorhynchos) shown with 16S rRNA gene-based
microbial community analysis. BioMed Res Int. 2013:4389562013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hunter P: Co-infection: when whole can be
greater than the sum: The complex reaction to co-infection of
different pathogens can generate variable symptoms. EMBO Rep.
19:e466012018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mushtaq I, Cheema HA and Malik HS, Waheed
N, Hashmi MA and Malik HS: Causes of chronic non-infectious
diarrhoea in infants less than 6 months of age: Rarely recognized
entities. J Ayub Med Coll Abbottabad. 29:78–82. 2017.PubMed/NCBI
|
|
28
|
Martins FS, Silva AA, Vieira AT, Barbosa
FH, Arantes RM, Teixeira MM and Nicoli JR: Comparative study of
Bifidobacterium animalis, Escherichia coli, Lactobacillus
casei and Saccharomyces boulardii probiotic properties.
Arch Microbiol. 191:623–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
El-Soud NH, Said RN, Mosallam DS, Barakat
NA and Sabry MA: Bifidobacterium lactis in treatment of
children with acute diarrhea. A randomized double blind controlled
trial. Open Access Maced J Med Sci. 3:403–407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akatsu H, Iwabuchi N, Xiao JZ, Matsuyama
Z, Kurihara R, Okuda K, Yamamoto T and Maruyama M: Clinical effects
of probiotic Bifidobacterium longum BB536 on immune function
and intestinal microbiota in elderly patients receiving enteral
tube feeding. JPEN J Parenter Enteral Nutr. 37:631–640. 2013.
View Article : Google Scholar : PubMed/NCBI
|
